Induction of Robust Cellular and Humoral Immunity against SARS-CoV-2 after a Third Dose of BNT162b2 Vaccine in Previously Unresponsive Older Adults

0
10
Researchers compared SARS-CoV-2-specific antibody and T cell responses between older adults and a younger control group after receiving two doses of BNT162b2.
[Nature Microbiology]

Sorry, but the selected Zotpress account can't be found.

Full Article